OneVentures 01 February 2022

Vale Grant Chamberlain

OneVentures

It is with great sadness that we advise that OneVentures Partner, Grant Chamberlain, has lost his life in a tragic accident over the weekend.

It was a privilege to have Grant in our team and to witness the impact he had in developing our people within OneVentures, and specifically for Growth Fund V.

We will always remember him as a respected leader and trusted colleague, expert financier and a fearless challenger to convention. From all of us who were mentored by him, supported by him, challenged by him and inspired by him – we want to honour Grant for the unique depth of experience that he gave to all of us.

No words can express how much we will miss him, as a colleague and as a friend.

Vale Grant Chamberlain.

Read more: The Australian Financial Review

You may also like

Sarah Meibusch, OneVentures Partner & Head of Healthcare

07 September 2026

Healthcare

Big pharma eyes Australian biotech as $300b patent cliff looms


17 April 2026

OneVentures

Meet the women steering Australia’s high-tech future

Read the full article: Australian Financial Review
afr.com/work-and-careers/leaders/meet-the-women-steering-australia-s-high-tech-future-20260210-p5o167

17 April 2026

Growth Credit

Eucalyptus sells to New York-listed healthcare giant in $1.6b deal

Read the full article: Australian Financial Review
afr.com/technology/eucalyptus-sells-to-new-york-listed-healthcare-giant-in-1-6b-deal-20260219-p5o3t4

12 January 2026

Healthcare

Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO

Read the full article: Global News Wire
globenewswire.com/news-release/2026/01/07/3214498/0/en/Vaxxas-Appoints-Former-Merck-Global-Vaccines-President-David-Peacock-as-CEO.html

View All